“TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now
A new ‘Open Access’ perspective paper by Grummet, J., Gorin, M.A., Popert, R. et al. as published in Springer Nature’s Prostate Cancer and Prostatic Diseases, is calling for the full, global eradication of the transrectal (TRUS) prostate biopsy to transperineal (TP) biopsy under local anaesthetic to be instigated in 2020.
The authors assert that “a well-planned global ‘TRexit’ with a phase-out period of TR biopsy led by centres experienced in TP biopsy, should be […] aiming for completion by the end of 2022.”
State of the Art Stokes Centre for Urology to host Two-day Uro-Oncology Masterclass covering latest Innovations in Prostate Cancer Pathway
On 20th & 21st November, Professor Stephen Langley and Dr Robert Laing will be hosting a Uro-Oncology Masterclass at the state-of-the-art Stokes Centre for Urology - a major centre for the treatment of prostate cancer both for the Surrey and Sussex Cancer Alliance and nationally.
BXTAccelyon and our partner Genesis Care are proud to be supporting this two day workshop, which will look at the latest technical innovations taking place in the prostate cancer pat...